{"log_id": 8582069564844827755, "direction": 0, "words_result_num": 49, "words_result": [{"probability": {"variance": 0.019432, "average": 0.920457, "min": 0.395054}, "location": {"width": 892, "top": 138, "height": 28, "left": 173}, "words": "心绞痛发作的频度和程度加重。因此,非选择性β受休阻滞剂不能用于此类患者选择性β受体阻滞"}, {"probability": {"variance": 0.025716, "average": 0.915777, "min": 0.507158}, "location": {"width": 203, "top": 171, "height": 25, "left": 172}, "words": "在使用时患必须慎重"}, {"probability": {"variance": 0, "average": 0.993888, "min": 0.993888}, "location": {"width": 34, "top": 161, "height": 34, "left": 1111}, "words": "骑"}, {"probability": {"variance": 0.015875, "average": 0.91569, "min": 0.55415}, "location": {"width": 846, "top": 202, "height": 27, "left": 219}, "words": "对支气管哮嘴或其他慢性摄赛性病患药,应同时给予足够的支气管治疗,2受体激动剂的剂"}, {"probability": {"variance": 0.016493, "average": 0.934269, "min": 0.647967}, "location": {"width": 145, "top": 235, "height": 25, "left": 172}, "words": "可能需要增加"}, {"probability": {"variance": 0.014432, "average": 0.93476, "min": 0.427418}, "location": {"width": 705, "top": 265, "height": 27, "left": 217}, "words": "美托洛尔的治疗对糖代谢的影或盖低血糖的危险低于非选择性β受体阻滞剂"}, {"probability": {"variance": 0.021536, "average": 0.937583, "min": 0.352303}, "location": {"width": 658, "top": 297, "height": 26, "left": 221}, "words": "在罕见的情况下,原有的中度房室传导异常可能重能导致房室阻潜)"}, {"probability": {"variance": 0.017484, "average": 0.94554, "min": 0.370489}, "location": {"width": 851, "top": 329, "height": 27, "left": 215}, "words": "β受体阻滞剂的疗可能会碍对过敏应的治疗,常规剂量的餐上腺素治疗并不总能得到预期"}, {"probability": {"variance": 0.024975, "average": 0.917206, "min": 0.375802}, "location": {"width": 606, "top": 361, "height": 26, "left": 171}, "words": "的疗效。嗜铬细胞瘤患者若使用本,考虑合并使用a受体阻滞剂"}, {"probability": {"variance": 0.019552, "average": 0.918047, "min": 0.428876}, "location": {"width": 848, "top": 391, "height": 27, "left": 219}, "words": "本品应尽可能逐步撤药,整个撤约过程至少用二周时间,润量逐渐减低:直至最后减至25mg(5mg"}, {"probability": {"variance": 0.023903, "average": 0.915434, "min": 0.350718}, "location": {"width": 893, "top": 423, "height": 25, "left": 172}, "words": "片的半片)。在此期,特别是对于已知有缺性心病的患者应进行密监测,在撤除β受体阻"}, {"probability": {"variance": 0.015211, "average": 0.945275, "min": 0.41766}, "location": {"width": 524, "top": 452, "height": 29, "left": 173}, "words": "剂期间,可能会使冠状动脉事件,包括心猝死的危险增加"}, {"probability": {"variance": 0.038188, "average": 0.851958, "min": 0.371848}, "location": {"width": 805, "top": 484, "height": 25, "left": 218}, "words": "在手术前应知医师者正在服用本。对接受手术的患者,不荐停用β受体阻到"}, {"probability": {"variance": 0.02156, "average": 0.942479, "min": 0.443746}, "location": {"width": 263, "top": 516, "height": 24, "left": 220}, "words": "对驾驶汽车和操作机械的影薄"}, {"probability": {"variance": 0.015516, "average": 0.93884, "min": 0.420946}, "location": {"width": 848, "top": 545, "height": 27, "left": 219}, "words": "在用本品治疗过程中可能会发生眩晕和劳,因此在需要集中注意力时,如驾驶和操作机械时应"}, {"probability": {"variance": 0.000337, "average": 0.983586, "min": 0.95954}, "location": {"width": 101, "top": 611, "height": 23, "left": 220}, "words": "运动员慎用"}, {"probability": {"variance": 0.012879, "average": 0.920925, "min": 0.630428}, "location": {"width": 236, "top": 655, "height": 24, "left": 176}, "words": "【孕妇及哺乳期妇女用药】"}, {"probability": {"variance": 0.00102, "average": 0.981519, "min": 0.84907}, "location": {"width": 849, "top": 684, "height": 28, "left": 219}, "words": "妊娠期使用β受体阻滞剂可引起胎儿各种问题,包括胎儿发育迟缓。β受体阻滞剂对胎儿和新生"}, {"probability": {"variance": 0.021563, "average": 0.90072, "min": 0.458251}, "location": {"width": 623, "top": 718, "height": 24, "left": 174}, "words": "儿可产生不利影,尤其是心动缓,因此查妊娠线分娩间不宣使用"}, {"probability": {"variance": 0.008232, "average": 0.963783, "min": 0.610908}, "location": {"width": 348, "top": 762, "height": 26, "left": 181}, "words": "【儿童用药】儿童使用本品的经验有限"}, {"probability": {"variance": 0.016955, "average": 0.94768, "min": 0.386485}, "location": {"width": 790, "top": 807, "height": 27, "left": 179}, "words": "【老年用药】老年人的药代动力学与年轻人比无明改变,因而老年患用量无需调整"}, {"probability": {"variance": 0.015348, "average": 0.89739, "min": 0.679023}, "location": {"width": 145, "top": 856, "height": 25, "left": 181}, "words": "【药物相互作翔"}, {"probability": {"variance": 0.019951, "average": 0.932767, "min": 0.361429}, "location": {"width": 851, "top": 886, "height": 25, "left": 220}, "words": "美托洛尔是一种CYP2D6的作用底物。抑制CYP2D6的药物可影响美尔的血浆浓度。制"}, {"probability": {"variance": 0.012647, "average": 0.923639, "min": 0.559213}, "location": {"width": 883, "top": 916, "height": 26, "left": 176}, "words": "CYP2D6的药物如尼丁、特比萘芬、帕罗西、氟西汀、舍曲林、塞来昔布、普罗帕酮和苯海拉明"}, {"probability": {"variance": 0.025223, "average": 0.9096, "min": 0.376793}, "location": {"width": 560, "top": 948, "height": 25, "left": 174}, "words": "对于服翔本晶的患者,在上述药物的治疗开始减低本的剂"}, {"probability": {"variance": 0.000922, "average": 0.983271, "min": 0.886664}, "location": {"width": 287, "top": 988, "height": 25, "left": 222}, "words": "本品应避免与下列药物合并使用"}, {"probability": {"variance": 0.033244, "average": 0.881669, "min": 0.361083}, "location": {"width": 839, "top": 1019, "height": 25, "left": 222}, "words": "巴比类药物:巴比采类药物(对巴比安作过研究)可通过酶诱导作期使美托尔的代美增加"}, {"probability": {"variance": 0.005479, "average": 0.956588, "min": 0.705131}, "location": {"width": 838, "top": 1050, "height": 27, "left": 222}, "words": "普罗帕酮:4例已经使用美托洛尔的患者,给予普罗帕后,美托洛尔的血浆浓度增高25倍"}, {"probability": {"variance": 0.027875, "average": 0.88983, "min": 0.375912}, "location": {"width": 895, "top": 1082, "height": 24, "left": 175}, "words": "中2例发生与美洛尔有关的副作用这种互作用在8健康志愿者中得到证实。对于这相互作"}, {"probability": {"variance": 0.012327, "average": 0.930715, "min": 0.540279}, "location": {"width": 898, "top": 1111, "height": 26, "left": 173}, "words": "用的可能的解释是,普罗帕酮与奎尼丁,可通过细胞色素P4502D6途径排制关托洛尔的代谢。由"}, {"probability": {"variance": 0.011754, "average": 0.944542, "min": 0.482384}, "location": {"width": 625, "top": 1142, "height": 26, "left": 177}, "words": "于普罗帕酮也具有β受体阻滞效应,其与美托洛尔的联合使用很难掌"}, {"probability": {"variance": 0.031875, "average": 0.883691, "min": 0.350431}, "location": {"width": 848, "top": 1182, "height": 26, "left": 222}, "words": "维拉米:维拉帕米与β受体阻剂食用时已有与替洛尔、普茶洛尔和水尔用的报道"}, {"probability": {"variance": 0.016107, "average": 0.933427, "min": 0.395044}, "location": {"width": 889, "top": 1214, "height": 25, "left": 175}, "words": "有可能引起心动过缓和血压下降维拉来和受体阴滞剂对于房室传导和窦房结功能有相加的抑制"}, {"probability": {"variance": 0, "average": 0.940602, "min": 0.940602}, "location": {"width": 20, "top": 1247, "height": 20, "left": 176}, "words": "用"}, {"probability": {"variance": 0.029086, "average": 0.904372, "min": 0.409091}, "location": {"width": 410, "top": 1286, "height": 23, "left": 225}, "words": "本与1药物合并使用时可能要调整量"}, {"probability": {"variance": 0.036325, "average": 0.85111, "min": 0.360109}, "location": {"width": 847, "top": 1314, "height": 25, "left": 222}, "words": "按碘:报道显示,国时使用碘酶和美洛尔,有可能发生明显的窦性心动过缓、按"}, {"probability": {"variance": 0.031996, "average": 0.84195, "min": 0.407179}, "location": {"width": 855, "top": 1345, "height": 25, "left": 178}, "words": "的期很长(约50天),这意味着在碘酮治疗停康后较长段时斑内,使用美托海尔有可"}, {"probability": {"variance": 0.080843, "average": 0.588992, "min": 0.362048}, "location": {"width": 161, "top": 1378, "height": 22, "left": 178}, "words": "药的用"}, {"probability": {"variance": 0.048643, "average": 0.759521, "min": 0.466692}, "location": {"width": 112, "top": 1362, "height": 54, "left": 1031}, "words": "医药有"}, {"probability": {"variance": 0.015686, "average": 0.938621, "min": 0.420343}, "location": {"width": 823, "top": 1404, "height": 32, "left": 225}, "words": "1类抗心率失药物:类抗心率失常物与β受体阻滞剂有的负性肌力作用,故"}, {"probability": {"variance": 0.028309, "average": 0.879579, "min": 0.384369}, "location": {"width": 891, "top": 1438, "height": 27, "left": 177}, "words": "功能换的患者中,有可能引超严重的血流动力学作,态窦房结综和病理性房室传"}, {"probability": {"variance": 0.032674, "average": 0.851394, "min": 0.399693}, "location": {"width": 818, "top": 1468, "height": 24, "left": 178}, "words": "者,避兔饲时使用美洛尔和类抗心失药物,丙按和美托涤尔之间的作用"}, {"probability": {"variance": 0, "average": 0.980388, "min": 0.980388}, "location": {"width": 120, "top": 1428, "height": 56, "left": 1074}, "words": "★"}, {"probability": {"variance": 0.020803, "average": 0.84536, "min": 0.573587}, "location": {"width": 99, "top": 1499, "height": 22, "left": 178}, "words": "的资料证明"}, {"probability": {"variance": 6e-06, "average": 0.998466, "min": 0.992694}, "location": {"width": 166, "top": 1475, "height": 55, "left": 1015}, "words": "质量管理专用章"}, {"probability": {"variance": 0.051268, "average": 0.808915, "min": 0.365279}, "location": {"width": 248, "top": 1530, "height": 24, "left": 225}, "words": "体抗风湿药(NS"}, {"probability": {"variance": 0.043905, "average": 0.771002, "min": 0.389664}, "location": {"width": 453, "top": 1530, "height": 24, "left": 543}, "words": "发现N袋D抗交镇的热酒受体的抗"}, {"probability": {"variance": 6e-06, "average": 0.991752, "min": 0.989706}, "location": {"width": 48, "top": 1523, "height": 28, "left": 1074}, "words": "(5)"}, {"probability": {"variance": 0.006156, "average": 0.896722, "min": 0.774494}, "location": {"width": 102, "top": 1601, "height": 36, "left": 1060}, "words": "仅供存档"}], "language": 3}